Hepatic Microcirculation in Fatty Liver Disease
Top Cited Papers
- 1 June 2008
- journal article
- review article
- Published by Wiley in The Anatomical Record
- Vol. 291 (6), 684-692
- https://doi.org/10.1002/ar.20715
Abstract
Nonalcoholic fatty liver disease (NAFLD), the most common cause of steatosis, is associated with visceral obesity and insulin resistance. With more severe risk factors (obesity, type 2 diabetes [T2D], metabolic syndrome), steatosis may be complicated by hepatocellular injury and liver inflammation (steatohepatitis or NASH). NASH can lead to perisinusoidal fibrosis and cirrhosis. Fat‐laden hepatocytes are swollen, and in steatohepatitis, further swelling occurs due to hydropic change (ballooning) of hepatocytes to cause sinusoidal distortion, as visualized by in vivo microscopy, reducing intrasinusoidal volume and microvascular blood flow. Involvement of other cell types (sinusoidal endothelial cells, Kupffer cells, stellate cells) and recruitment of inflammatory cells and platelets lead to dysregulation of microvascular blood flow. In animal models, the net effect of such changes is a marked reduction of sinusoidal space (∼50% of control), and a decrease in the number of normally perfused sinusoids. Such microvascular damage could accentuate further liver injury and disease progression in NASH. The fatty liver is also exquisitely sensitive to ischemia‐reperfusion injury, at least partly due to the propensity of unsaturated fatty acids to undergo lipid peroxidation in the face of reactive oxygen species (ROS). This has important clinical consequences, particularly limiting the use of fatty donor livers for transplantation. In this review, we discuss available data about the effects of steatosis and steatohepatitis on the hepatic microvascular structure and sinusoidal blood flow, highlighting areas for future investigation. Anat Rec, 291:684–692, 2008.Keywords
This publication has 66 references indexed in Scilit:
- Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelinesJournal of Gastroenterology and Hepatology, 2007
- Optimal Utilization of Donor Grafts With Extended CriteriaAnnals of Surgery, 2006
- Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant miceBiochemical and Biophysical Research Communications, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Steatosis: Co-factor in other liver diseasesHepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- Use of steatotic graft in living-donor liver transplantationTransplantation, 2003
- Body mass index as a predictor of hepatic steatosis in living liver donorsLiver Transplantation, 2001
- ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1Transplantation, 2001
- Effect of extended cold ischaemia with UW solution on graft function after liver transplantationThe Lancet, 1992